Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Oncology Center of Excellence

Oncology Center of Excellence

                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community Home
          About FDA
          FDA Organization
          Oncology Center of Excellence
          Who We Are - Oncology Center of ExcellenceOncology Center of Excellence Who We Are - Oncology Center of Excellence
  
  	
    Share
    Post
    Linkedin

    Email
    PrintImage
              We are OCEAuthorized by the 21st Century Cures Act, the OCE was established on January 19, 2017, to facilitate the development and clinical review of oncology products by uniting scientific experts across the FDA’s product centers to conduct expedited review of drugs, biologics, and devices.

Oncology Center of Excellence (OCE) Leadership

Center Director: Richard Pazdur, MD
Deputy Center Director: Paul G. Kluetz, MD
Deputy Center Director: Marc R. Theoret, MD
Director for Regulatory Affairs and Regulatory Policy: Tamy Kim, PharmD

Director, Oncology Program Operations:****Sherwin Sapasap, MS, MBA, MHA

**OCE Associate Directors**

**Biomarkers and Precision Oncology:** Reena Philip, PhD

**Cardio-Oncology:**Laleh Amiri-Kordestani, MD

**Cell and Gene Therapy:** vacant

**Communications:** Kirsten Goldberg, MA

**Education:** Jennifer Gao, MD

**External Outreach and Engagement:**Rea Blakey, BS

**Global Clinical Sciences:** Angelo de Claro, MD

**Global Regulatory Outreach:** Dianne Spillman, BS

**Oncology Devices:** Dorian M. Korz, MD

**Oncology in Older Adults and Special Populations:**Harpreet Singh, MD

**Oncology In vitro Diagnostics:** vacant

**Oncology Labeling:**William Pierce, PharmD, MPH, BCPS

**Patient Outcomes:** Vishal Bhatnagar, MD

**Pediatric Oncology and Rare Cancers:** Martha Donoghue, MD

**Pharmacoepidemiology and Oncology RWE:** Donna Rivera, PharmD, MS

**Project Renewal Clinical Director**: Sundeep Agrawal, MD

**Safety:**Abhilasha Nair, MD

**Science & Policy to Address Disparities:** Lola Fashoyin-Aje, MD, MPH

**Strategy and Partnership:**Julie Schneider, PhD

**Tissue Agnostic Drug Development:** Steven Lemery, MD

How Oncology Center of Excellence (OCE) Review Works With FDA Product Centers

Applicants submit applications to the product center they normally would, and those centers decide whether the product will be under an expedited program. For products selected, the OCE forms a Medical Oncology Review and Evaluation (MORE) team that includes a medical oncology specialist and specialists from the relevant product center.

The MORE team:

Provides a unified clinical review to promote development of safe and effective oncology products.
	Builds on cross-center collaboration by providing input to selected INDs that are under expedited program.
	Implements common decision-making standards for Breakthrough Therapy and Fast Track designation for all oncology therapeutic products.The completed clinical review is sent to the product center, which makes the final application approval determination, taking into account both clinical and non-clinical information.

FDA Product Centers Working With OCE

CDER Office of Oncologic Diseases

Immediate Office
	Division of Oncology 1 (DO1)
	Division of Oncology 2 (DO2)
	Division of Oncology 3 (DO3)
	Division of Hematologic Malignancies 1 (DHM1)
	Division of Hematologic Malignancies 2 (DHM2)
	Division of Hematology Oncology ToxicologyCenter for Devices and Radiological Health

Center for Biologics Evaluation and Research

Cellular and Gene Therapy
	Vaccines

                                                                                  Content current as of:
      02/09/2023Oncology Center of Excellence

          
                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop